Rollins, Inc.

NYSE:ROL

Personal Products & Services

Consumer Cyclical
$37.70 -0.53%

-$0.24 today

Market cap
$18.02B
Beta
0.73
P/E (TTM)
40.8
EPS (TTM)
$1.10
Dividend yield
1.59%
52W Low $44.43High $66.14

Volume 4.00M

Average 3.74M

ROL Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Rollins, Inc.NYSE: ROL

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMSep 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How ROL compares with its peers on the latest reported figures

  • ROL's LTM Sep 2026 research & development of $0 is the 2nd highest of the 5 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for ROL, versus a peer median of 0.0%.
ROL Competitors Peer median
Research & Development for ROL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FMCFMC CorporationLTM Mar 2026$262.9M -8.0%-5.4%7.7%
ROLRollins, Inc.LTM Sep 2026$0 ——0.0%
CTASCintas CorporationLTM Aug 2026$0 -100.0%—0.0%
ECLEcolab Inc.LTM Jun 2026$0 -100.0%—0.0%
RTORentokil Initial plcFY2025$0 -100.0%—0.0%
Peer median (excluding ROL) $0-100.0%-5.4%0.0%

Competitors are the stored peer set for ROL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.42B2.7B3.07B3.39B3.76B
Cost of Revenue1.16B1.31B1.47B1.6B1.78B
Gross Profit1.26B1.39B1.6B1.79B1.98B
Gross Margin52.0%51.5%52.2%52.7%52.8%
Research & Development00000
Selling, General & Admin727.49M802.71M915.23M1.02B1.13B
Operating Expenses814.05M894.04M1.02B1.13B1.26B
Depreciation & Amortization86.56M91.33M99.75M113.22M124.74M
EBITDA569.87M592.88M688.17M771.13M854.01M
EBITDA Margin23.5%22.0%22.4%22.8%22.7%
Operating Income447.64M493.39M583.23M657.22M726.07M
Operating Margin18.5%18.3%19.0%19.4%19.3%
Interest Income00000
Interest Expense830K2.64M19.06M27.68M28.56M
Other Income / Expenses34.85M5.53M3.03M(26.99M)(25.14M)
Income Before Tax482.49M498.92M586.26M630.23M700.93M
Pre-Tax Margin19.9%18.5%19.1%18.6%18.6%
Income Tax Expense125.92M130.32M151.3M163.85M174.22M
Net Income356.57M368.6M434.96M466.38M526.71M
Net Margin14.7%13.7%14.2%13.8%14.0%
EPS (Basic)0.720.750.890.961.09
EPS (Diluted)0.720.750.890.961.09
Weighted Avg Shares492.05M492.3M489.95M484.25M484.11M
Weighted Avg Shares (Diluted)492.05M492.41M490.13M484.3M484.15M

Rollins, Inc.

NYSE:ROL

Intrinsic Alpha fair value

Locked

Current Price

$37.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.